A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

NACompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

August 1, 2023

Study Completion Date

December 1, 2023

Conditions
Nephrolithiasis
Interventions
DEVICE

Holmium laser lithotripsy with Moses Technology

Holmium laser energy will be delivered for the ureteroscopic fragmenting of kidney stones. Energy will be generated by the commercial available, FDA approved Lumenis PulseTM P120H laser system and Moses laser fiber. Renal stones will be fragmented using a dusting technique. Moses laser settings will be turned on.

DEVICE

Holmium laser lithotripsy without Moses Technology

Holmium laser energy will be delivered for the ureteroscopic fragmenting of kidney stones. Energy will be generated by the commercial available, FDA approved Lumenis PulseTM P120H laser system and Moses laser fiber. Renal stones will be fragmented using a dusting technique. Moses laser settings will be turned off.

Trial Locations (6)

10032

Columbia University, New York

27710

Duke University Medical Center, Durham

37232

Vanderbilt University Medical Center, Nashville

44195

Cleveland Clinic, Cleveland

85054

Mayo Clinic, Phoenix

92103

University of California San Diego, San Diego

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04505956 - A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology | Biotech Hunter | Biotech Hunter